Want to join the conversation?
$VTR expects its 2016 reported normalized FFO per diluted share to range from $4.07-4.15, representing 3-5% growth over 2015 on a comparable basis. The company expects its 2016 NAREIT reported FFO per diluted share to be $4.13-4.21. Total company same-store cash net operating income is forecast to grow 1.5-3.0% in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?